Literature DB >> 24661728

SK channel blockade reverses cognitive and motor deficits induced by nigrostriatal dopamine lesions in rats.

Lin Chen1, Thierry Deltheil1, Nathalie Turle-Lorenzo1, Martine Liberge1, Corinne Rosier1, Isabelle Watabe2, Leam Sreng3, Marianne Amalric1, Christiane Mourre1.   

Abstract

Parkinson's disease has traditionally been viewed as a motor disorder caused by the loss of dopamine (DA) neurons. However, emotional and cognitive syndromes can precede the onset of the motor deficits and provide an opportunity for therapeutic intervention. Potassium channels have recently emerged as potential new targets in the treatment of Parkinson's disease. The selective blockade of small conductance calcium-activated K+ channels (SK channels) by apamin is known to increase burst firing in midbrain DA neurons and therefore DA release. We thus investigated the effects of systemic administration of apamin on the motor, cognitive deficits and anxiety present after bilateral nigrostriatal 6-hydroxydopamine (6-OHDA) lesions in rats. Apamin administration (0.1 or 0.3 mg/kg i.p.) counteracted the depression, anxiety-like behaviors evaluated on sucrose consumption and in the elevated plus maze, social recognition and spatial memory deficits produced by partial 6-OHDA lesions. Apamin also reduced asymmetric motor deficits on circling behavior and postural adjustments in the unilateral extensive 6-OHDA model. The partial 6-OHDA lesions (56% striatal DA depletion) produced 20% decrease of iodinated apamin binding sites in the substantia nigra pars compacta in correlation with the loss of tyrosine hydroxylase positive cells, without modifying apamin binding in brain regions receiving DAergic innervation. Striatal extracellular levels of DA, not detectable after 6-OHDA lesions, were enhanced by apamin treatment as measured by in vivo microdialysis. These results indicate that blocking SK channels may reinstate minimal DA activity in the striatum to alleviate the non-motor symptoms induced by partial striatal DA lesions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24661728     DOI: 10.1017/S1461145714000236

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  15 in total

Review 1.  SK2 channel regulation of neuronal excitability, synaptic transmission, and brain rhythmic activity in health and diseases.

Authors:  Jiandong Sun; Yan Liu; Michel Baudry; Xiaoning Bi
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2020-08-27       Impact factor: 4.739

Review 2.  Potassium Channels: A Potential Therapeutic Target for Parkinson's Disease.

Authors:  Xiaoyan Chen; Bao Xue; Jun Wang; Haixia Liu; Limin Shi; Junxia Xie
Journal:  Neurosci Bull       Date:  2017-09-07       Impact factor: 5.203

3.  Bee Venom for the Treatment of Parkinson Disease - A Randomized Controlled Clinical Trial.

Authors:  Andreas Hartmann; Julia Müllner; Niklaus Meier; Helke Hesekamp; Priscilla van Meerbeeck; Marie-Odile Habert; Aurélie Kas; Marie-Laure Tanguy; Merry Mazmanian; Hervé Oya; Nissen Abuaf; Hafida Gaouar; Sabrina Salhi; Fanny Charbonnier-Beaupel; Marie-Hélène Fievet; Damien Galanaud; Sophie Arguillere; Emmanuel Roze; Bertrand Degos; David Grabli; Lucette Lacomblez; Cécile Hubsch; Marie Vidailhet; Anne-Marie Bonnet; Jean-Christophe Corvol; Michael Schüpbach
Journal:  PLoS One       Date:  2016-07-12       Impact factor: 3.240

4.  Chronic social isolation reduces 5-HT neuronal activity via upregulated SK3 calcium-activated potassium channels.

Authors:  Derya Sargin; David K Oliver; Evelyn K Lambe
Journal:  Elife       Date:  2016-11-22       Impact factor: 8.140

Review 5.  Emerging preclinical pharmacological targets for Parkinson's disease.

Authors:  Sandeep Vasant More; Dong-Kug Choi
Journal:  Oncotarget       Date:  2016-05-17

Review 6.  Physiology and Therapeutic Potential of SK, H, and M Medium AfterHyperPolarization Ion Channels.

Authors:  Deepanjali Dwivedi; Upinder S Bhalla
Journal:  Front Mol Neurosci       Date:  2021-06-03       Impact factor: 5.639

Review 7.  What can rodent models tell us about apathy and associated neuropsychiatric symptoms in Parkinson's disease?

Authors:  R Magnard; Y Vachez; C Carcenac; P Krack; O David; M Savasta; S Boulet; S Carnicella
Journal:  Transl Psychiatry       Date:  2016-03-08       Impact factor: 6.222

8.  Bee Venom Alleviates Motor Deficits and Modulates the Transfer of Cortical Information through the Basal Ganglia in Rat Models of Parkinson's Disease.

Authors:  Nicolas Maurice; Thierry Deltheil; Christophe Melon; Bertrand Degos; Christiane Mourre; Marianne Amalric; Lydia Kerkerian-Le Goff
Journal:  PLoS One       Date:  2015-11-16       Impact factor: 3.240

Review 9.  Physiological Roles and Therapeutic Potential of Ca2+ Activated Potassium Channels in the Nervous System.

Authors:  Aravind S Kshatri; Alberto Gonzalez-Hernandez; Teresa Giraldez
Journal:  Front Mol Neurosci       Date:  2018-07-30       Impact factor: 5.639

10.  Kcnn2 blockade reverses learning deficits in a mouse model of fetal alcohol spectrum disorders.

Authors:  Shahid Mohammad; Stephen J Page; Li Wang; Seiji Ishii; Peijun Li; Toru Sasaki; Aiesha Basha; Anna Salzberg; Zenaide Quezado; Fumiaki Imamura; Hirotaka Nishi; Keiichi Isaka; Joshua G Corbin; Judy S Liu; Yuka Imamura Kawasawa; Masaaki Torii; Kazue Hashimoto-Torii
Journal:  Nat Neurosci       Date:  2020-03-16       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.